Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox® antimicrobial potency study (ZAPS-Europe)

This publication has 31 references indexed in Scilit:

• In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial
  Journal of Antimicrobial Chemotherapy, 2001
• Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999)
  Diagnostic Microbiology and Infectious Disease, 2000
• In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains
  Antimicrobial Agents and Chemotherapy, 2000
• Oxazolidinones
  Drugs, 2000
• Mechanism of action of the oxazolidinone antibacterial agents
  Expert Opinion on Investigational Drugs, 1999
• Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
  Diagnostic Microbiology and Infectious Disease, 1998
• Gram-positive resistance: challenge for the development of new antibiotics
  Journal of Antimicrobial Chemotherapy, 1997
• Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
  The American Journal of Medicine, 1996
• Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections
  Journal of Medicinal Chemistry, 1996
• Emerging Resistance to Antimicrobial Agents in Gram-Positive Bacteria
  Drugs, 1996